Mr. Speaker, there is no question about it that there has to be a vaccine plan globally, because there are risks associated with other types of variants that are going to develop in these nations. It is up to the global community to come together and make sure that, for those countries that are vulnerable and susceptible to these types of variants manifesting themselves, we come together and really work as a global community to make sure that those countries are safe. By extension, Canada becomes safe as well.
We do need domestic capacity as well and I really want to emphasize the need for biopharma. Pharmaceutical technology in this country needs to be developed, not just talked about but actually done.